Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Keros Therapeutics Inc
Swot
Keros Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Keros Therapeutics Inc has 12 Strengths, 9 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(9)
Opportunity
(1)
Threats
(2)
Others
(0)
Price crossing above SMA20 today, and greater than SMA5
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Company with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
